I should probably quit beating this drum, but I cannot resist this one. From the Washington Post's Health Reform Watch, Jason Millman writes about the new FDA biosimilars news:
The Food and Drug and Administration for the first time has accepted an application for a copycat version of what's known as a biologic, which is a complex drug made from proteins of living organisms. These biologics are cutting-edge therapies that can be more effective than regular drugs made from chemicals — and, not surprisingly, they also can be expensive.What's the right way to talk about this? Do you go back to "everything is chemicals", or do you say "small molecules"? I dunno.